The role of the immune system in regulating the microbiota

References

• Marchesi J, Shanahan F. The normal intestinal microbiota. Curr Opin Infect Dis 2007; 20:508 - 513
   PubMed Web of Science ®Google Scholar
• Hooper LV, Bry L, Falk PG, Gordon JI. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays 1998; 20:336 - 343
   PubMed Web of Science ®Google Scholar
• Hudault S, Guignot J, Servin AL. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut 2001; 49:47 - 55
   PubMed Web of Science ®Google Scholar
• Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007; 5:2177 - 189
   PubMed Web of Science ®Google Scholar
• Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol 2004; 12:129 - 134
   PubMed Web of Science ®Google Scholar
• Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106:3698 - 3703
   PubMed Web of Science ®Google Scholar
• Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008; 105:2117 - 2122
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027 - 1031
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109 - 1110
   PubMed Web of Science ®Google Scholar
• Sekirov I, Tam NM, Jogova M, Robertson ML, Li YL, Lupp C, et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008; 76:4726 - 4736
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317:124 - 127
   PubMed Web of Science ®Google Scholar
• Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, Halfvarson J, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009; 3:179 - 189
   PubMed Web of Science ®Google Scholar
• Zoetendal EG, Akkermans ADL, Akkermans-van Vliet WM, Arjan J, de Visser GM, de Vos WM. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis 2001; 13:129 - 134
   Google Scholar
• Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflam Bowel Dis 2008; 14:147 - 161
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107 - 118
   PubMed Web of Science ®Google Scholar
• Umesaki Y, Okada Y, Matsumoto S, Imaoka A, Setoyama H. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class-II molecules and fucosyl asialo Gm1 glycolipids on the small-intestinal epithelial-cells in the ex-germ-free mouse. Microbiol Immunol 1995; 39:555 - 562
   PubMed Web of Science ®Google Scholar
• Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115 - 1118
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229 - 241
   PubMed Web of Science ®Google Scholar
• Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99:15451 - 1545
   PubMed Web of Science ®Google Scholar
• Cebra JJ. Influences of microbiota on intestinal immune system development. Amer J Clin Nutr 1999; 69:1046 - 1051
   PubMed Web of Science ®Google Scholar
• Ivanov II, de Frutos RL, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4:337 - 349
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;
   PubMed Web of Science ®Google Scholar
• Umesaki Y, Setoyama H, Matsumoto S, Imaoka A, Itoh K. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 1999; 67:3504 - 3511
   PubMed Web of Science ®Google Scholar
• Rask C, Evertsson S, Telemo E, Wold AE. A full flora, but not monocolonization by Escherichia coli or lactobacilli, supports tolerogenic processing of a fed antigen. Scand J Immunol 2005; 61:529 - 535
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, Bier D, Marteau P, Rechkemmer G, Bourdet-Sicard R, Walker WA, et al. Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediat Gastroenterol Nutr 2009; 48:126 - 141
   PubMed Web of Science ®Google Scholar
• Vidal K, Benyacoub J, Moser M, Sanchez-Garcia J, Serrant P, Segura-Roggero I, et al. Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice. Rejuv Res 2008; 11:957 - 964
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511 - 521
   PubMed Web of Science ®Google Scholar
• Adlerberth I. Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutr Workshop Ser Pediatr Program 2008; 62:13 - 29
   PubMedGoogle Scholar
• Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635 - 1638
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480 - 484
   PubMed Web of Science ®Google Scholar
• Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11:2574 - 2584
   PubMed Web of Science ®Google Scholar
• Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cel 2006; 124:837 - 848
   PubMed Web of Science ®Google Scholar
• Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915 - 1920
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by Deep 16S rRNA sequencing. PLoS Biol 2008; 6:2383 - 2400
   Web of Science ®Google Scholar
• Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One 2009; 4:6386
   PubMed Web of Science ®Google Scholar
• Claus SP, Tsang TM, Wang YL, Cloarec O, Skordi E, Martin FP, et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 2008; 4:219
   PubMed Web of Science ®Google Scholar
• Rawls JF, Mahowald MA, Ley RE, Gordon JI. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 2006; 127:423 - 433
   PubMed Web of Science ®Google Scholar
• Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, et al. Evolution of mammals and their gut microbes. Science 2008; 320:1647 - 1651
   PubMed Web of Science ®Google Scholar
• Tannock GW. The search for disease-associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol 2008; 16:488 - 495
   PubMed Web of Science ®Google Scholar
• Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, Engstrand L. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflam Bowel Dis 2009; 15:653 - 660
   PubMed Web of Science ®Google Scholar
• Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1:56 - 66
   PubMed Web of Science ®Google Scholar
• Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.. Cell Host Microbe 2007; 2:119 - 129
   PubMed Web of Science ®Google Scholar
• Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 2008; 76:907 - 915
   PubMed Web of Science ®Google Scholar
• Bender A, Breves G, Stein J, Leonhard-Marek S, Schroder B, Winckler C. Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model. Zeitschrift Fur Gastroenterologie 2001; 39:911
   PubMed Web of Science ®Google Scholar
• Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189 - 220
   PubMed Web of Science ®Google Scholar
• Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001; 13:458 - 464
   PubMed Web of Science ®Google Scholar
• Freihorst J, Ogra PL. Mucosal immunity and viral infections. Ann Med 2001; 33:172 - 177
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Nat Acad Sci USA 2008; 105:15064 - 15069
   PubMed Web of Science ®Google Scholar
• Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001; 280:922 - 929
   PubMed Web of Science ®Google Scholar
• Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Nat Acad Sci USA 2009; 106:5859 - 5864
   PubMed Web of Science ®Google Scholar
• Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG. Probiotics upregulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediat Surg Internat 2002; 18:586 - 590
   PubMed Web of Science ®Google Scholar
• Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003; 52:827 - 833
   PubMed Web of Science ®Google Scholar
• Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol-Gastrointest Liver Physiol 1999; 276:941 - 950
   PubMed Web of Science ®Google Scholar
• Hooper L, Xu J, Falk P, Midtvedt T, Gordon J. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Nat Acad Sci USA 1999; 96:9833 - 9838
   PubMed Web of Science ®Google Scholar
• Torrespinedo R, Mahmood A. Postnatal changes in biosynthesis of microvillus membrane glycans of rat small-intestine 1. Evidence of a developmental shift from terminal sialylation to fucosylation. Biochem Bioph Res Co 1984; 125:546 - 553
   PubMed Web of Science ®Google Scholar
• Ouellette AJ, Greco RM, James M, Frederick D, Naftilan J, Fallon JT. Developmental regulation of cryptdin, a corticostatin defensin precursor messenger-RNA in mouse sall intestinal crypt epithelium. J Cell Biol 1989; 108:1687 - 1695
   PubMed Web of Science ®Google Scholar
• Harwig SSL, Tan L, Qu XD, Cho Y, Eisenhauer PB, Lehrer RI. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 1995; 95:603 - 610
   PubMed Web of Science ®Google Scholar
• Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nature Immunol 2004; 5:836 - 843
   PubMed Web of Science ®Google Scholar
• Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313:1126 - 1130
   PubMed Web of Science ®Google Scholar
• Ganz T. Antimicrobial polypeptides. J Leukocyte Biol 2004; 75:34 - 38
   PubMed Web of Science ®Google Scholar
• Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular phospholipase-A2 expression and inflammation—the relationship with associated disease states. J Lipid Mediators 1993; 8:1 - 30
   PubMedGoogle Scholar
• Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008; 455:804 - 808
   PubMed Web of Science ®Google Scholar
• Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nature Immunol 2005; 6:551 - 557
   PubMed Web of Science ®Google Scholar
• Hecht G. Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol-Cell Physiol 1999; 277:351 - 358
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Nat Acad Sci USA 2005; 102:18129 - 18134
   PubMed Web of Science ®Google Scholar
• Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nature Immunol 2010; 11:76 - 83
   PubMed Web of Science ®Google Scholar
• Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70:953 - 963
   PubMed Web of Science ®Google Scholar
• Bals R, Wilson JM. Cathelicidins—a family of multifunctional antimicrobial peptides. Cellular Molec Life Sci 2003; 60:711 - 720
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Chen CT, Gordon JI. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 2006; 4:413
   PubMed Web of Science ®Google Scholar
• Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Putsep K, et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008; 57:764 - 771
   PubMed Web of Science ®Google Scholar
• Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Nat Acad Sci USA 2009; 106:15813 - 15818
   PubMed Web of Science ®Google Scholar
• Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174:4453 - 4460
   PubMed Web of Science ®Google Scholar
• Sanderson IR, Walker WA. TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis. Am J Physiol-Gastrointest Liver Physiol 2007; 292:6 - 10
   Web of Science ®Google Scholar
• Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 2008; 27:234 - 243
   PubMed Web of Science ®Google Scholar
• Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003; 52:840 - 846
   PubMed Web of Science ®Google Scholar
• Honda K, Takeda K. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol 2009; 2:187 - 196
   PubMed Web of Science ®Google Scholar
• Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MAE, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617 - 620
   PubMed Web of Science ®Google Scholar
• Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Nat Acad Sci USA 2008; 105:20858 - 20863
   PubMed Web of Science ®Google Scholar
• Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167:1882 - 1885
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007; 117:3909 - 3921
   PubMed Web of Science ®Google Scholar
• Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol-Gastrointest Liver Physiol 2006; 290:1157 - 1163
   PubMed Web of Science ®Google Scholar
• Jima DD, Shah RN, Orcutt TM, Joshi D, Law JM, Litman GW, et al. Enhanced transcription of complement and coagulation genes in the absence of adaptive immunity. Mol Immunol 2009; 46:1505 - 1516
   PubMed Web of Science ®Google Scholar
• Keilbaugh SA, Shin ME, Banchereau RF, McVay LD, Boyko N, Artis D, et al. Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut. Gut 2005; 54:623 - 629
   PubMed Web of Science ®Google Scholar
• Izcue A, Coombes JL, Powrie F. Regulatory lymphocytes and intestinal inflammation. Ann Rev Immunol 2009; 27:313 - 338
   PubMed Web of Science ®Google Scholar
• Kelsall BL. Innate and adaptive mechanisms to control pathological intestinal inflammation. J Pathol 2008; 214:242 - 259
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303:1662 - 1665
   PubMed Web of Science ®Google Scholar
• Toivanen P, Vaahtovuo J, Eerola E. Influence of major histocompatibility complex on bacterial composition of fecal flora. Infect Immun 2001; 69:2372 - 2377
   PubMed Web of Science ®Google Scholar
• Suzuki K, Ha SA, Tsuji M, Fagarasan S. Intestinal IgA synthesis: A primitive form of adaptive immunity that regulates microbial communities in the gut. Seminars Immunol 2007; 19:127 - 135
   PubMed Web of Science ®Google Scholar
• Mestecky J, Russell MW. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol Lett 2009; 124:57 - 62
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288:2222 - 2226
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25:5467 - 5484
   PubMed Web of Science ®Google Scholar
• Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002; 298:1424 - 1427
   PubMed Web of Science ®Google Scholar
• Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T, et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Nat Acad Sci USA 2004; 101:1981 - 1986
   PubMed Web of Science ®Google Scholar
• Harris NL, Spoerri I, Schopfer JF, Nembrini C, Merky P, Massacand J, et al. Mechanisms of neonatal mucosal antibody protection. J Immunol 2006; 177:6256 - 6262
   PubMed Web of Science ®Google Scholar
• Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007; 2:328 - 339
   PubMed Web of Science ®Google Scholar
• Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nature Gen 2008; 40:1319 - 1323
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263 - 274
   PubMed Web of Science ®Google Scholar
• Spencer SD, Di Marco F, Hooley J, Pitts-Meek S, Bauer M, Ryan AM, et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 1998; 187:571 - 578
   PubMed Web of Science ®Google Scholar
• Moore KW, Malefyt RD, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol 2001; 19:683 - 765
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+CD25+ T-R cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197:111 - 119
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biologic Chem 2003; 278:1910 - 1914
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179 - 189
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu JF, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445:648 - 651
   PubMed Web of Science ®Google Scholar
• Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: Effector T cells with inflammatory properties. Seminars Immunol 2007; 19:362 - 371
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008; 118:534 - 544
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008; 29:947 - 957
   PubMed Web of Science ®Google Scholar
• Ismail AS, Behrendt CL, Hooper LV. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol 2009; 182:3047 - 3054
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Prot Res 2007; 6:546 - 551
   PubMed Web of Science ®Google Scholar
• Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685 - 693
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflam Bowel Dis 2006; 12:106 - 111
   PubMed Web of Science ®Google Scholar
• Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006; 44:3980 - 3988
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205 - 211
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43:3380 - 3389
   PubMed Web of Science ®Google Scholar
• Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, Apajalahti J, et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2008; 2:716 - 727
   PubMed Web of Science ®Google Scholar
• Giaffer MH, Holdsworth CD, Duerden BI. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel-disease. Gut 1992; 33:646 - 650
   PubMed Web of Science ®Google Scholar
• Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+ D phylogenetic group in inflammatory bowel disease. Gut 2007; 56:669 - 675
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterol 2002; 122:44 - 54
   PubMed Web of Science ®Google Scholar
• Willing B, Halfvarson J, Dicksved J, Rosenqist M, Järnerot G, Engstrand L, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009; 15:653 - 660
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Nat Acad Sci USA 2008; 105:16731 - 16736
   PubMed Web of Science ®Google Scholar
• Fuss IJ. Is the Th1/Th2 paradigm of immune regulation applicable to IBD?. Inflamm Bowel Dis 2008; 14:110 - 112
   PubMed Web of Science ®Google Scholar
• Grassl GA, Valdez Y, Bergstrom KSB, Vallance BA, Finlay BB. Chronic enteric Salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterol 2008; 134:768 - 780
   PubMed Web of Science ®Google Scholar
• Mokrowiecka A, Daniel P, Slomka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepato-Gastroenterol 2009; 56:162 - 166
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced paneth cell alpha-defensins and antimicrobial activity in ileal Crohn's disease. Inflamm Bowel Dis 2006; 12:20
   Web of Science ®Google Scholar
• Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, et al. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.. Clin Immunol 2007; 125:281 - 290
   PubMed Web of Science ®Google Scholar
• Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009; 294:1 - 8
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ. Host-bacteria homeostasis in the healthy and inflamed gut. Curr Opin Gastroenterol 2008; 24:435 - 439
   PubMed Web of Science ®Google Scholar
• Amit-Romach E, Uni Z, Cheled S, Berkovich Z, Reifen R. Bacterial population and innate immunity-related genes in rat gastrointestinal tract are altered by vitamin A-deficient diet. J Nutr Biochem 2009; 20:70 - 77
   PubMed Web of Science ®Google Scholar
• Kinross J, von Roon AC, Penney N, Holmes E, Silk D, Nicholson JK, et al. The gut microbiota as a target for improved surgical outcome and improved patient care. Curr Pharmaceut Design 2009; 15:1537 - 1545
   PubMed Web of Science ®Google Scholar